-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1

Benzinga·03/28/2025 11:42:29
Listen to the news
Leerink Partners analyst Thomas Smith downgrades Equillium (NASDAQ:EQ) from Outperform to Market Perform and lowers the price target from $3 to $1.